NovoCure Limited

NASDAQ: NVCR · Real-Time Price · USD
11.73
0.14 (1.21%)
At close: Aug 15, 2025, 3:59 PM
11.79
0.51%
After-hours: Aug 15, 2025, 05:59 PM EDT

NovoCure Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-170.95M -164.19M -168.63M -149.78M -168.7M -192.74M -207.04M -197.27M -174.36M -140.95M -92.53M -81.69M -68.24M -58.87M -58.35M -26.98M -4.57M 11.73M
Depreciation & Amortization
5.68M 5.09M 11.23M 10.85M 11.2M 11.06M 10.97M 10.95M 10.8M 10.73M 10.62M 10.59M 10.66M 10.49M 10.25M 10.06M 9.51M 9.63M
Stock-Based Compensation
149.82M 155.5M 160.03M 114.72M 109.7M 110.61M 115.61M 127.95M 127.91M 120.99M 106.95M 99.57M 99.02M 101.08M 94.9M 92.78M 87.14M 78.03M
Other Working Capital
23.6M 21.87M 19.82M -84K -4.07M -12.47M -13.21M -10.4M -5.53M 376.65K 1.24M -12.93M -13.54M -14.59M -17.08M -10.67M -13.36M -12.65M
Other Non-Cash Items
-13.59M 16.32M 12.62M 12.73M 13.31M -15.02M -16.43M -17.09M -10.62M -13.24M -7.21M 2.02M 2.55M 3.25M 3.01M 6.23M 5.87M 4.4M
Deferred Income Tax
n/a n/a n/a -1.91M -395K -6.09M -6.09M -4.19M -5.7M n/a n/a 389K 997K 1.55M 3.88M 3.51M 2.94M 2.06M
Change in Working Capital
-15.63M -5.96M -5.21M 12.33M 4.14M 3.19M 29.66M 17.16M 31.21M 39.04M 11.8M 16.86M 4.72M 3.79M 29.07M 36.24M 27.51M 9.12M
Operating Cash Flow
-44.68M -30.46M -26.37M -37.48M -67.17M -88.18M -73.34M -62.48M -20.75M 17.75M 30.79M 48.9M 50.88M 61.29M 82.76M 121.83M 128.4M 114.97M
Capital Expenditures
-35.72M -41.68M -42.85M -40.73M -37.3M -32.79M -27.09M -26.7M -25.15M -22.35M -21.36M -29.2M -26.8M -25.28M -24.17M -15.65M -15.14M -15.84M
Cash Acquisitions
n/a n/a n/a -105.32M -129.83M -122.87M -211.24M 15.71M 184.76M 177.79M 266.17M 144.54M n/a n/a n/a n/a n/a n/a
Purchase of Investments
-846.78M -991.25M -875.39M -885.35M -967.26M -765.83M -1B -1.04B -1.29B -1.24B -1.3B -1.56B -1.1B -820.13M -1.08B -1.2B -1.16B -1.16B
Sales Maturities Of Investments
900M 640M 778M 906.55M 992.1M 1.15B 1.21B 1.02B 1.1B 1.23B 1.18B 1.07B 1.07B 629M 958M 958M 758M 758M
Other Investing Acitivies
n/a -362.99M -104.99M 327K 24.84M 380.87M 211.24M -15.71M -184.76M -17.91M -118.6M -481.79M -31.25M -191.13M -120.66M -243.73M -399.73M -399.73M
Investing Cash Flow
17.5M -392.93M -140.24M -19.53M -12.47M 348.08M 184.15M -42.41M -209.91M -40.26M -139.96M -510.99M -58.04M -216.41M -144.83M -259.38M -414.87M -415.56M
Debt Repayment
n/a 84.01M 84.01M 84.01M 84.01M -3K -10K -17K -24K -28K -28K -28K -27K -27K -26K 558.41M 408.41M 408.41M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
6.32M 7.19M 2.16M 1.81M 2.88M 6.38M 11.38M 11.96M 15M 12.36M 10.29M 10.83M 9.66M 16.37M 21.18M 32.12M 38.59M 33.58M
Financial Cash Flow
10.42M 95.35M 90.31M 89.54M 90.61M 10.8M 15.79M 17.29M 20.32M 17.55M 15.49M 15.73M 14.56M 20.89M 25.7M 592.9M 449.38M 443.66M
Net Cash Flow
-16.31M -327.93M -76.47M 32.69M 10.95M 270.72M 126.73M -87.52M -210.27M -4.99M -93.78M -446.66M 7.18M -134.35M -36.56M 455.31M 163M 143.27M
Free Cash Flow
-80.4M -72.14M -69.22M -78.21M -104.47M -120.97M -100.43M -89.19M -45.9M -4.61M 9.43M 19.7M 24.08M 36.01M 58.59M 106.18M 113.26M 99.13M